Pasi Janne
机构: Dana Farber Cancer Institute
每年引用次数
引用次数
引用: 134,728
H-指数: 163
I10-指数 : 547
出版物: 1,257
A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
Sarita Dubey , Pasi A. Jänne , Lee Krug , Herbert Pang
Journal of Thoracic Oncology 5 ( 10) 1655 -1661
98
2010
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma
Taylor M. Ortiz , David W. Cohen , Michael S. Kent , Pasi A. Jänne
Journal of Thoracic Oncology 6 ( 1) 220 -222
2011
Welcome to the Chicago Multidisciplinary Symposium in Thoracic Oncology
Stephen Hahn , Pasi A. Jänne
Journal of Thoracic Oncology 7 ( 9) S202
2012
The Introduction of Systematic Genomic Testing for Patients With Non-Small-Cell Lung Cancer
Stephanie Cardarella , Taylor M. Ortiz , Victoria A. Joshi , Mohit Butaney
Journal of Thoracic Oncology 7 ( 12) 1767 -1774
111
2012
Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions
Geoffrey R. Oxnard , Peter C. Lo , Mizuki Nishino , Suzanne E. Dahlberg
Journal of Thoracic Oncology 8 ( 2) 179 -184
277
2013
Epidermal growth factor receptor inhibition in lung cancer: Status 2012
Fred R Hirsch , Pasi A Jänne , Wilfried E Eberhardt , Federico Cappuzzo
Journal of Thoracic Oncology 8 ( 3) 373 -384
105
2013
Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.
Mizuki Nishino , Suzanne E. Dahlberg , Stephanie Cardarella , David M. Jackman
Journal of Thoracic Oncology 8 ( 8) 1059 -1068
35
2013
Concurrent Docetaxel and Thoracic Radiation in non—small-Cell Lung Cancer
Pasi A. Jänne , Arthur T. Skarin
Clinical Lung Cancer 3
3
2002
Chemotherapy for malignant pleural mesothelioma.
Pasi A. Jänne
Clinical Lung Cancer 5 ( 2) 98 -106
44
2003
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
Pasi A. Jänne , Antoinette J. Wozniak , Chandra P. Belani , Mary-Louise Keohan
Clinical Lung Cancer 7 ( 1) 40 -46
132
2005
Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor†
Sang Min Lim , Kenneth D. Westover , Scott B. Ficarro , Rane A. Harrison
Angewandte Chemie 53 ( 1) 199 -204
327
2014
Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America: Meaningful improvements in survival
Pasi A. Jänne , Boris Freidlin , Scott Saxman , David H. Johnson
Cancer 95 ( 7) 1528 -1538
223
2002
Chemotherapy for a Patient with Advanced Non-Small-Cell Lung Cancer during Pregnancy: A Case Report and a Review of Chemotherapy Treatment during Pregnancy
Pasi A. Jänne , Diana Rodriguez-Thompson , Dianne R. Metcalf , Scott J. Swanson
Oncology 61 ( 3) 175 -183
47
2001
Disrupted Sperm Function and Fertilin β Processing in Mice Deficient in the Inositol Polyphosphate 5-Phosphatase Inpp5b
Elina Hellsten , Janice P. Evans , David J. Bernard , Pasi A. Jänne
Developmental Biology 240 ( 2) 641 -653
40
2001
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Kenneth N. Ross , Teresa Moran , Emily Howe , Linnea E. Fulton
Nature Communications 6 ( 1) 6377 -6377
504
2015
Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor Biology
Pasi A. Jänne , Jeffrey A. Engelman , Bruce E. Johnson
Journal of Clinical Oncology 23 ( 14) 3227 -3234
348
2005
Abstract CT079: ELUXA 1: Ph II study of BI1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)
Sai-Hong Ou , Keunchil Park , Ji-Youn Han , Dong-Wan Kim
Cancer Research 76
1
2016
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
Geoffrey R. Oxnard , Yuebi Hu , Kathryn F. Mileham , Hatim Husain
JAMA Oncology 4 ( 11) 1527 -1534
495
2018
Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer
Adrian G. Sacher , Suzanne E. Dahlberg , Jennifer Heng , Stacy Mach
JAMA Oncology 2 ( 3) 313 -320
160
2016
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
Adrian G Sacher , Cloud Paweletz , Suzanne E Dahlberg , Ryan S Alden
JAMA Oncology 2 ( 8) 1014 -1022
556
2016